# LEVOCETIRIZINE DIHYDROCHLORIDE
> **ANDA213513** · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LTD III · Approved 2020-04-29
## Drug
- **FDA Application Number:** ANDA213513
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LEVOCETIRIZINE DIHYDROCHLORIDE
- **Generic name:** LEVOCETIRIZINE DIHYDROCHLORIDE 5 MG
- **Active ingredients:** LEVOCETIRIZINE DIHYDROCHLORIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Over-the-counter
- **Sponsor:** HETERO LABS LTD III
- **Manufacturer:** Little Pharma, Inc.
- **First approval:** 2020-04-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213513)
---
*AI Analytics · CC0 1.0*